Skip to main content
Fig. 2 | Molecular Medicine

Fig. 2

From: Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis

Fig. 2

The outcome of different CAF risk in stage II/III CRC patients. AC The DFS of patients with different CAF risk group in training cohort (A), TCGA cohort (B) and meta-validation cohort (C). DF Kaplan–Meier curves comparing patients with different risk in training cohort (D), TCGA cohort (E) and meta-validation cohort (F)

Back to article page